Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 5Polycystic Ovary Syndrome 2Obesity 2Leukemia, Myeloid, Acute 2Head and Neck Neoplasms 2Endometrial Neoplasms 2Triple Negative Breast Neoplasms 1Tracheal Diseases 1TP53 Y220C Mutation 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Overweight 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Motor Activity 1Mesothelioma 1Meningioma 1Medulloblastoma 1Lymphoma 1Lung Neoplasms 1Localized Prostate Cancer 1Leukemia 1Leiomyosarcoma 1

Interventions

Tablets 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Localized Prostate Cancer × Tablets × Clear all
NCT06966778 2026-03-16

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

National Taiwan University Hospital

Phase NA Recruiting
135 enrolled
Genitourinary

Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡